Company profile
DiaVacs company profile
The company potentially addresses the disadvantages of prior approaches by offering local antigen-specific immunosuppression, halting the pathogenic autoimmune response without compromising the body's immune system, and complements emerging regenerative approaches by protecting newly created beta cells from autoimmune attack, enabling patients to get rid from lifelong dependency on insulin.
Business identity
- Website
- https://www.diavacs.com
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00051-00100 employees
- Founded
- 2013-01-01
Headquarters
- Headquarters
- Aitkin, Minnesota, United States
- Postal code
- 07020
- Country code
- US
- Continent
- North America